Activation of Src-family tyrosine kinases during fas-induced apoptosis

Journal of Leukocyte Biology

Volumn 60, Issue 4, 1996, Pages 546-554

  Schlottmann, Klaus E ^a   Gulbins, Erich ^b   Lau, Sey M ^a   Coggeshall, K Mark ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

CD95; Lck; Lymphocytes; Tyrphostins

Indexed keywords

FAS ANTIGEN; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE KINASE INHIBITOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LYMPHOBLASTOID CELL; MOUSE; NONHUMAN; ONCOGENE SRC; PHOSPHORYLATION; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALIA; MURINAE;

EID: 0029861838     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.60.4.546     Document Type: Article

References (60)

1. Trauth, B. C., Klas, C., Peters, A. M., Matzku, S., Moller, P., Falk, W., Debatin, K. M., Krammer, P. H. (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301-305.
2. Yonehara, S., Ishii, A., Yonehara, M. (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756.
3. Itoh, N., Yonehara, S., Ishii, A., Yonehara, M., Mizushima, S., Sameshima, M., Hase, A., Seto, Y., Nagata, S. (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243.
4. Watanabe-Fukunaga, R., Brannan, C. I., Itoh, N., Yonehara, S., Copeland, N. G., Jenkins, N. A., Nagata, S. (1992) The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274-1279.
5. Watanabe-Fukunaga, R., Brannan, C. I., Copeland, N. G., Jenkins, N. A., Nagata, S. (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317.
6. Takahashi, T., Tanaka, M., Brannan, C. I., Jenkins, N, A., Copeland, N. C., Suda, T., Nagata, S. (1994) Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976.
7. Fisher, G. H., Rosenberg, F. J., Straus, S. E., Dale, J. K., Middleton, L. A., Lin, A. Y., Strober, W., Lenardo, M. J., Puck, J. M. (1995) Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946.
8. Rieux-Laucat, F., Le Deist, F., Hivroz, C., Roberts, I. A., Debatin, K. M., Fischer, A., de Villartay, J. P. (1995) Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349.
9. Kobayashi, N., Hamamoto, Y., Yamamoto, N., Ishii, A., Yonehara, M., Yonehara, S. (1990) Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication. Proc. Natl. Acad. Sci. USA 87, 9620-9624.
10. Katsikis, P. D., Wunderlich, E. S., Smith, C. A., Herzenberg, L. A., Herzenberg, L. A. (1995) Fas antigen stimulation induces marked apoptosis of T lymphocytes in human immunodeficiency virus-infected individuals. J. Exp. Med. 181, 2029-2036.
11. Westendorp, M. O., Frank, R., Ochsenbauer, C., Stricker, K., Dhein, J., Walczak, H., Debatin, K. M., Krammer, P. H. (1995) Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375, 497-500.
12. Dhein, J., Walczak, H., Baumler, C., Debatin, K. M., Krammer, P. H. (1995) Autocrine T-cell suicide mediated by APO-1/(Fas/CD95) [see comments]. Nature 373, 438-441.
13. Brunner, T., Mogil, R. J., LaFace, D., Yoo, N. J., Mahboubi, A., Echeverri, F., Martin, S. J., Force, W. R., Lynch, D. H., Ware, C. F., et al. (1995) Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas [see comments]. Nature 373, 441-444.
14. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., el-Khatib, M., Sherr, D. H., Stanger, B. Z., Marshak-Rothstein, A. (1995) Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation [see comments]. Nature 373, 444-448.
15. Singer, G. G., Abbas, A. K. (1994) The fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365-371.
16. Debatin, K. M., Suss, D., Krammer, P. H. (1994) Differential expression of APO-1 on human thymocytes: implications for negative selection? Eur. J. Immunol. 24, 753-758.
17. Galle, P. R., Hofmann, W. J., Walczak, H., Schaller, H., Otto, G., Stremmel, W., Krammer, P. H., Runkell, L. (1995) Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J. Exp. Med. 182, 1223-1230.
18. Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., Ferguson, T. A. (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270, 1189-1192.
19. Suda, T., Takahashi, T., Golstein, P., Nagata, S. (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75, 1169-1178.
20. Dhein, J., Daniel, P. T., Trauth, B. C., Oehm, A., Moller, P., Krammer, P. H. (1992) Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J. Immunol. 149, 3166-3173.
21. Tartaglia, L. A., Ayres, T. M., Wong, G. H., Goeddel, D. V. (1993) A novel domain within the 55 kd TNF receptor signals cell death. Cell 74, 845-853.
22. Hofmann, K., Tschopp, J. (1995) The death domain motif found in Fas (Apo-1 and TNF receptor is present in proteins involved in apoptosis and axonal guidance. Fed. Eur. Biochem. Soc. 371, 321-323.
23. Rudert, F., Roos, M., Forbes, L., Watson, J. (1994) Apoptosis in L929 cells expressing a CD40/Fas chimeric receptor: dissociation of stimulatory from inhibitory death signalling functions. Biochem. Biophys. Res. Commun. 204, 1102-1110.
24. Boldin, M. P., Mett, I. L., Varfolomeev, E. E., Chumakov, I., Shemer-Avni, Y., Camonis, J. H., Wallach, D. (1995) Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects. J. Biol. Chem. 270, 387-391.
25. Boldin, M. P., Varfolomeev, E. E., Pancer, Z., Mett, I. L., Camonis, J. H., Wallach, D. (1995) A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798.
26. Chinnaiyan, A. M., O'Rourke, K., Tewari, M., Dixit, V. M. (1995) FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512.
27. Stanger, B. Z., Leder, P., Lee, T. H., Kim, E., Seed, B. (1995) RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81, 513-523.
28. Kischkel, F. C., Hellbardt, S., Behrmann, I., Germer, M., Pawlita, M., Krammer, P. H., Peter, M. E. (1995) Cytotoxicity-dependent APO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. Eur. Mol. Biol. Org. J. 14, 5579-5588.
29. Sato, T., Irie, S., Kitada, S., Reed, J. C. (1995) FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268, 411-415.
30. Cifone, M. G., De Maria, R., Roncaioli, P., Rippo, M. R., Azuma, M., Lanier, L. L., Santoni, A., Testi, R. (1994) Apoptotic signaling through CD95 (Fas/Apo-1) activates an acidic sphingomyelinase. J. Exp. Med 180, 1547-1552.
31. Gulbins, E., Bissonnette, R., Mahboubi, A., Martin, S., Nishioka, W., Brunner, T., Baier, G., Baier-Bitterlich, G., Byrd, C., Lang, F., et al. (1995) FAS-induced apoptosis is mediated via a ceramide-initialed RAS signaling pathway. Immunity 2, 341-351.
32. Tepper, C. G., Jayadev, S., Liu, B., Bielawska, A., Wolff, R., Yonehara, S., Hannun, Y. A., Seldin, M. F. (1995) Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc. Natl. Acad. Sci. USA 92, 8443-8447.
33. Dressler, K. A., Mathias, S., Kolesnick, R. N. (1992) Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science 255, 1715-1718.
34. Obeid, L. M., Linardic, C. M., Karolak, L. A., Hannun, Y. A. (1993) Programmed cell death induced by ceramide. Science 259, 1769-1771.
35. Cifone, M. G., Roncaioli, P., De Maria, R., Camarda, G., Santoni, A., Ruberti, G., Testi, R. (1995) Multiple pathways originate at the Fas/Apo-1 (CD95) receptor: sequential involvement of phosphatidylcholine-specific phospholipase C and acidic sphingomyelinase in the propagation of the apoptotic signal. J. Biol. Chem. 14, 5859-5868.
36. Eischen, C. M., Dick, C. J., Leibson, P. J. (1994) Tyrosine kinase activation provides an early and requisite signal for Fas-induced apoptosis. J. Immunol. 153, 1947-1954.
37. Schraven, B., Peter, M. E. (1995) APO-1 (CD95)-mediated apoptosis in Jurkat cells does not involve src kinases or CD45. FEBS Lett. 368, 491-494.
38. Atkinson, E. A., Ostergaard, H., Kane, K., Pinkoski, M. J., Caputo, A., Olszowi, M. W., Bleackley, R. C. (1996) Physical interaction between the cell death protein Fas and the tyrosine kinase p59fynT. J. Biol. Chem. 271, 5968-5971.
39. Gazit, A., Yaish, P., Gilon, C., Levitzki, A. (1989) Tyrphostins I: synthesis and biological activity of protein tyrosine kinase inhibitors. J. Med. Chem. 32, 2344-2352.
40. Gazit, A., Osherov, N., Posner, I., Yaish, P., Poradosu, E., Gilon, C., Levitzki, A. (1991) Tyrphostins. 2. Heterocyclic and alpha-substituted benzylidene-malononitrile tyrphostins as potent inhibitors of EGF receptor and ErbB2/neu tyrosine kinases. J. Med. Chem . 34, 1896-907.
41. Jones, B., Tite, J. P., Janeway, C. A., Jr. (1986) Different phenotypic variants of the mouse B cell tumor A20/2J are selected by antigen- and mitogen-triggered cytotoxicity of L3T4-positive, I-A-restricted T cell clones. J. Immunol. 136, 348-356.
42. Yang, Y., Mercep, M., Ware, C. F., Ashwell, J. D. (1995) Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: inhibition of Fas ligand expression by retinoic acid and glucocorticoids. J. Exp. Med. 181, 1673-1682.
43. Shan, B., Durfee, T., Lee, W. H. (1996) Disruption of RB/E2F-1 interaction by single point mutations in E2F-1 enhances S-phase entry and apoptosis. Proc. Natl. Acad. Sci. USA 93, 679-684.
44. Rivero-Lezcano, O. M., Sameshima, J. H., Marcilla, A., Robbins, K. C. (1994) Physical association between Src homology 3 elements and the protein product of the c-cbl proto-oncogene. J. Biol. Chem. 269, 17363-17366.
45. Donovan, J. A., Wange, R. L., Langdon, W. Y., Samelson, L. E. (1994) The protein product of the c-cbl protooncogene is the 120-kDa tyrosine-phosphorylated protein in Jurkal cells activated via the T cell antigen receptor. J. Biol. Chem. 269, 22921-22924.
46. Holmes, W. E., Lee, J., Kuang, W. J., Rice, G. C., Wood, W. I. (1991) Structure and functional expression of a human interleukin-8 receptor. Science 253, 1278-1280.
47. Straus, D. B., Weiss, A. (1992) Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptor. Cell 70, 585-593.
48. Klas, C., Debatin, K. M., Jonker, R. R., Krammer, P. H. (1993) Activation interferes with the APO-1 pathway in mature human T cells. Int. Immunol. 5, 625-630.
49. Caron, L., Abraham, N., Pawson, T., Veillette, A. (1992) Structural requirements for enhancement of T-cell responsiveness by the lymphocyte-specific tyrosine protein kinase p561ck. Mol. Cell. Biol. 12, 2720-2729.
50. Su, X., Zhou, T., Wang, Z., Yang, P., Jope, R. S., Mountz, J. D. (1995) Defective expression of hematopoietic cell protein tyrosine phosphatase (HCP) in lymphoid cells blocks Fas-mediated apoptosis. Immunity 2, 353-362.
51. Justement, L. B., Campbell, K. S., Chien, N. C., Cambier, J. C. (1991) Regulation of B cell antigen receptor signal transduction and phosphorylation by CD45. Science 252, 1839-1842.
52. D'Ambrosio, D., Hippen, K. L., Minskoff, S. A., Mellman, I., Pani, G., Siminovitch, K. A., Cambier, J. C. (1995) Recruitment and activation of PTPlC in negative regulation of antigen receptor signaling by Fc gamma RIIB1 [see comments]. Science 268, 293-297.
53. Azuma, Y., Onishi, Y., Sato, Y., Kizaki, H. (1993) Induction of mouse thymocyte apoptosis by inhibitors of tyrosine kinases is associated with dephosphorylation of nuclear proteins. Cell. Immunol. 152, 271-278.
54. Knox, K. A., Gordon, J. (1993) Protein tyrosine phosphorylation is mandatory for CD40-mediated rescue of germinal center B cells from apoptosis. Eur. J. Immunol. 23, 2578-2584.
55. Spinozzi, F., Pagliacci, M. C., Migliorati, G., Moraca, R., Grignani, F., Riccardi, C., Nicoletti, I. (1994) The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukemia cells. Leukemia Res. 18, 431-439.
56. Bergamaschi, G., Rosti, V., Danova, M., Ponchio, L., Lucotti, C., Cazzola, M. (1993) Inhibitors of tyrosine phosphorylation induce apoptosis in human leukemic cell lines. Leukemia 7, 2012-2018.
57. Gorezyca, W., Gong, J., Ardelt, B., Traganos, F., Darzynkiewicz, Z. (1993) The cell cycle related differences in susceptibility of HL-60 cells to apoptosis induced by various antitumor agents. Cancer Res. 53, 3186-3192.
58. Agbotounou, W. K., Levitzki, A., Jacquemin-Sablon, A., Pierre, J. (1994) Effects of tyrphostins on the activated c-src protein in NIH/3T3 cells. Mol. Pharmacol. 45, 922-931.
59. Markovits, J., Larsen, A. K., Segal-Bendirdjian, E., Fosse, P., Saucier, J. M., Gazit, A., Levitzki, A., Umezawa, K., Jacquemin-Sablon, A. (1994) Inhibition of DNA topoisomerases I and II and induction of apoptosis by erbstatin and tyrphostin derivatives. Biochem. Pharmacol. 48, 549-560.
60. Agbotounou, W. K., Mousset, S., Piperno, S., Pierre, M., Jacquemin-Sablon, A., Pierre, J. (1994) Activation of the mitogen-activated protein kinase cascade by tyrphostin (RG 50864). Biochem. Pharmacol. 48, 505-515.